Received: 17 October 2019
Accepted: 31 January 2020
First Online: 11 February 2020
Ethics approval and consent to participate
: The analysis used anonymized data extracted from patients’ electronic medical records and was compliant with New Zealand national privacy regulations on the use of patient data. Patients provided verbal informed consent to CxbM testing, and to the surveillance protocol, following a written disclosure and in accordance with consent procedures used for local treatment protocols, and thus with appropriate local ethics oversight (and not requiring written informed consent). The Health and Disabilities Ethics Committee (HDEC) determined that the study was undertaken to assess diagnostic quality as part of the standard of care and did not require approval.
: Not applicable.
: The authors declare that they have no competing interests. Anne Schuckman is a consultant for Photocure.